Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

MBX Biosciences (MBX) Shares Outstanding (2023 - 2026)

MBX Biosciences has reported Shares Outstanding over the past 4 years, most recently at $47.6 million for Q1 2026.

  • Quarterly results put Shares Outstanding at $47.6 million for Q1 2026, up 42.32% from a year ago — trailing twelve months through Mar 2026 was $47.6 million (up 42.32% YoY), and the annual figure for FY2025 was $44.9 million, up 34.43%.
  • Shares Outstanding reached $47.6 million in Q1 2026 per MBX's latest filing, up from $44.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $47.6 million in Q1 2026 and bottomed at $1.2 million in Q3 2023.
  • Median Shares Outstanding over the past 4 years was $33.4 million (2024), compared with a mean of $25.1 million.
  • The largest annual shift saw Shares Outstanding soared 2572.12% in 2024 before it skyrocketed 33.97% in 2025.
  • Over 4 years, Shares Outstanding stood at $1.3 million in 2023, then skyrocketed by 2558.66% to $33.4 million in 2024, then skyrocketed by 34.43% to $44.9 million in 2025, then increased by 5.88% to $47.6 million in 2026.
  • Business Quant data shows Shares Outstanding for MBX at $47.6 million in Q1 2026, $44.9 million in Q4 2025, and $44.7 million in Q3 2025.